Osmotherapy in neurocritical care
- PMID: 17999898
- DOI: 10.1007/s11910-007-0079-2
Osmotherapy in neurocritical care
Abstract
Osmotherapy is the mainstay in the medical management of cerebral edema with or without elevations in intracranial pressure. Several osmotic agents have been utilized in clinical practice over the past five decades in a variety of brain injury paradigms. The over-riding premise for their beneficial effects has been via egress of water from the brain into the vascular compartment. In addition, many of these agents have beneficial extraosmotic properties that portend their use in cerebral resuscitation and treatment of cerebral edema. Although there is a paucity of large, randomized clinical trials that compare various osmotic agents, data are emerging from prospective clinical case series. This article provides a historical perspective of osmotherapy, examines characteristics of osmotic agents, and discusses caveats in their use in the clinical setting. Furthermore, this review highlights the utility of osmotic agents as tools to understand emerging mechanistic concepts in the evolution of brain edema, which are yielding important data of translational significance from laboratory-based research.
Similar articles
-
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.Neurocrit Care. 2020 Jun;32(3):647-666. doi: 10.1007/s12028-020-00959-7. Neurocrit Care. 2020. PMID: 32227294 Free PMC article.
-
Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline.AACN Clin Issues. 2005 Apr-Jun;16(2):199-211. doi: 10.1097/00044067-200504000-00011. AACN Clin Issues. 2005. PMID: 15876888 Review.
-
Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature.Br J Clin Pharmacol. 2018 Apr;84(4):636-648. doi: 10.1111/bcp.13492. Epub 2018 Jan 18. Br J Clin Pharmacol. 2018. PMID: 29247499 Free PMC article.
-
Current status of osmotherapy in intracerebral hemorrhage.Neurol India. 2003 Mar;51(1):104-9. Neurol India. 2003. PMID: 12865537 Review. No abstract available.
-
Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury--a study of cerebral blood flow and metabolism.Acta Neurochir (Wien). 2006 Aug;148(8):845-51; discussion 851. doi: 10.1007/s00701-006-0792-7. Epub 2006 Jun 12. Acta Neurochir (Wien). 2006. PMID: 16763735 Clinical Trial.
Cited by
-
Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4.Neurocrit Care. 2010 Aug;13(1):123-31. doi: 10.1007/s12028-010-9376-8. Neurocrit Care. 2010. PMID: 20458553
-
Mechanics of the brain: perspectives, challenges, and opportunities.Biomech Model Mechanobiol. 2015 Oct;14(5):931-65. doi: 10.1007/s10237-015-0662-4. Epub 2015 Feb 26. Biomech Model Mechanobiol. 2015. PMID: 25716305 Free PMC article. Review.
-
Evaluation of the Maintained Effect of 3% Hypertonic Saline Solution in an Animal Model of Intracranial Hypertension.Med Sci Monit Basic Res. 2016 Oct 25;22:123-127. doi: 10.12659/msmbr.899661. Med Sci Monit Basic Res. 2016. PMID: 27777397 Free PMC article.
-
Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.Cell Microbiol. 2010 Jun;12(6):740-53. doi: 10.1111/j.1462-5822.2010.01430.x. Epub 2010 Jan 11. Cell Microbiol. 2010. PMID: 20070311 Free PMC article.
-
Synovial Fluid of Patient With Rheumatoid Arthritis Enhanced Osmotic Sensitivity Through the Cytotoxic Edema Module in Synoviocytes.Front Cell Dev Biol. 2021 Aug 31;9:700879. doi: 10.3389/fcell.2021.700879. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34532317 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous